Snowball logo
logo
4503_logo

Astellas Pharma Inc.

¥2,356.50+¥94.00  (4.15%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
1,296,1631,518,6191,603,6721,912,3232,139,2452,274,365
COGS
253,009288,353292,485349,206544,408575,188
Gross Profit
1,043,1541,230,2661,311,1871,563,1171,594,8371,699,177
Operating Expenses & Income
Operating Income
220,021285,430178,070255,672419,698495,937
Total Operating Expenses
823,133944,8361,133,1171,307,4451,175,1391,203,240
R&D Expenses
246,000276,100294,200327,700314,827324,858
Selling General & Admin Expenses
548,840630,272740,110843,032860,312-
Earnings from Continuing Operations
Interest Expense
(4,949)(8,779)(9,368)(17,677)(14,072)(11,295)
Interest Income
6,1498,11011,4557,8748,026-
Income Tax Expense
32,80033,6477,924(19,510)85,013107,781
Net Income
Net Income
124,08698,71417,04550,747291,535364,829
Supplemental
EBIT
218,145231,652124,606263,540390,659480,122
EBITDA
297,829337,390282,446462,672585,253676,800
In millions of JPY, except % and values per 1 share